Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision on the page updated from v3.2.0 to v3.3.2. The change appears to be a site version update and does not affect the study details.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding notice about potential delays and operating status has been removed.SummaryDifference0.4%

- Check43 days agoChange DetectedThe page update appears to be a cosmetic/layout change with no alteration to core study information (title, eligibility criteria, interventions, outcomes, contacts, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference6%

- Check78 days agoChange DetectedCore page content remains the same; added contact details (phone numbers and email) and updated version to v3.1.0. Removed version v3.0.2.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.